Overview

Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and efficacy of memantine extended release, as well as its extent of absorption in pediatric patients with autism.
Phase:
Phase 2
Details
Lead Sponsor:
Forest Laboratories
Collaborator:
Merz Pharmaceuticals GmbH
Treatments:
Memantine